Postmastectomy radiotherapy for all node positive patients: The case against

J.m. Dixon, I.h. Kunkler*, N. Russell, C. Thomssen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Postmastectomy radiotherapy (PMRT) is accepted as the standard of care for women with early breast cancer with 4 or more involved axillary nodes. However the role of PMRT in women with 1–3 involved nodes remains controversial and guidelines vary.

We present the arguments against advocating postmastectomy radiotherapy for all women with node positive breast cancer.
Original languageEnglish
Pages (from-to)2515-2520
Number of pages6
JournalEuropean Journal of Surgical Oncology (EJSO)
Issue number10
Publication statusPublished - 28 Jun 2021

Keywords / Materials (for Non-textual outputs)

  • postmastectomy radiotherapy
  • breast cancer


Dive into the research topics of 'Postmastectomy radiotherapy for all node positive patients: The case against'. Together they form a unique fingerprint.

Cite this